David A Solomon Selected Research

Adenomatoid Tumor

1/2019	Well-differentiated papillary mesothelioma of the peritoneum is genetically defined by mutually exclusive mutations in TRAF7 and CDC42.
1/2018	Adenomatoid tumors of the male and female genital tract are defined by TRAF7 mutations that drive aberrant NF-kB pathway activation.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

David A Solomon Research Topics

Disease

57	Neoplasms (Cancer) 05/2024 - 08/2003
20	Glioma (Gliomas) 11/2023 - 12/2011
9	Glioblastoma (Glioblastoma Multiforme) 12/2023 - 04/2008
9	Astrocytoma (Pilocytic Astrocytoma) 12/2022 - 12/2011
8	Meningioma (Meningiomas) 05/2024 - 05/2019
6	Bipolar Disorder (Manic Depressive Psychosis) 07/2014 - 12/2006
4	Retinoblastoma (Glioblastoma, Retinal) 07/2009 - 08/2003
3	Aneuploidy (Aneuploid) 01/2022 - 08/2011
3	Oligodendroglioma 01/2022 - 01/2017
3	Mesothelioma 01/2019 - 01/2017
3	Carcinogenesis 01/2017 - 08/2003
2	Ganglioglioma 12/2022 - 01/2018
2	Infections 03/2020 - 01/2018
2	Neoplasm Metastasis (Metastasis) 01/2020 - 12/2017
2	Epilepsy (Aura) 10/2019 - 01/2018
2	Adenomatoid Tumor 01/2019 - 01/2018
2	Medulloblastoma 01/2019 - 09/2017
2	Malignant Mesothelioma 01/2019 - 01/2017
2	Carcinoma (Carcinomatosis) 01/2018 - 12/2013
2	Depressive Disorder (Melancholia) 07/2014 - 02/2004
2	Major Depressive Disorder (Major Depressive Disorders) 07/2014 - 03/2005
2	Mood Disorders (Mood Disorder) 07/2014 - 07/2005
2	Dysthymic Disorder 07/2005 - 03/2004
1	Nerve Sheath Neoplasms (Nerve Sheath Neoplasm) 12/2023
1	Neurilemmoma (Schwannoma) 12/2023
1	Solitary Fibrous Tumors 01/2022
1	Spinal Injuries (Spinal Injury) 08/2021
1	Hemangioma (Angioma) 01/2021
1	Primitive Neuroectodermal Tumors (PNET) 01/2021
1	Angiomatoid Fibrous Histiocytoma 01/2021
1	Paraganglioma (Paragangliomas) 12/2020
1	Vasculitis (Vasculitides) 03/2020
1	Teratoma (Teratoid Tumor) 01/2020
1	Neuroepithelial Neoplasms (Gliomatosis Cerebri) 01/2020
1	Neurocytoma 01/2020
1	Germ Cell and Embryonal Neoplasms (Germ Cell Tumor) 01/2019

Drug/Important Bio-Agent (IBA)

10	DNA (Deoxyribonucleic Acid)IBA 12/2023 - 01/2017
7	Biomarkers (Surrogate Marker)IBA 12/2023 - 03/2020
7	Histones (Histone)IBA 08/2021 - 01/2016
7	CohesinsIBA 11/2019 - 08/2011
5	RNA (Ribonucleic Acid)IBA 05/2024 - 01/2020
5	Phosphotransferases (Kinase)IBA 01/2020 - 01/2018
5	Antidepressive Agents (Antidepressants)IBA 07/2014 - 03/2005
4	Proteins (Proteins, Gene)FDA Link 05/2024 - 07/2009
3	Isocitrate Dehydrogenase (Isocitrate Dehydrogenase (NAD+))IBA 01/2022 - 12/2017
3	Temozolomide (Temodar)FDA LinkGeneric 11/2021 - 04/2010
2	Transcription Factors (Transcription Factor)IBA 12/2023 - 01/2023
2	Everolimus FDA Link 11/2023 - 12/2022
2	SynaptophysinIBA 01/2023 - 01/2021
2	Formaldehyde (Formol)FDA Link 12/2022 - 01/2020
2	ParaffinIBA 12/2022 - 01/2020
2	Mitogen-Activated Protein Kinase Kinases (MEKs)IBA 12/2022 - 10/2022
2	DesminIBA 01/2021 - 01/2020
2	Keratins (Keratin)IBA 12/2020 - 01/2020
2	2,6-dinitrotoluene (DNT)IBA 01/2020 - 01/2018
2	NF-kappa B (NF-kB)IBA 01/2019 - 01/2018
2	Neural Cell Adhesion Molecule L1 (L1 Cell Adhesion Molecule)IBA 01/2019 - 01/2018
2	Cyclin-Dependent Kinases (cdk Proteins)IBA 04/2010 - 04/2008
2	CyclinsIBA 04/2008 - 08/2003
2	Tumor Suppressor Proteins (Proteins, Tumor Suppressor)IBA 11/2003 - 08/2003
1	DNA-Directed DNA Polymerase (Polymerases, DNA)IBA 12/2023
1	Immune Checkpoint InhibitorsIBA 12/2023
1	ChromatinIBA 12/2023
1	Protein Isoforms (Isoforms)IBA 12/2023
1	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 12/2023
1	LuciferasesIBA 12/2023
1	Ribosomal Protein S6IBA 11/2023
1	Phosphatidylinositol 3-Kinase (1 Phosphatidylinositol 3 Kinase)IBA 11/2023
1	TOR Serine-Threonine KinasesIBA 11/2023
1	CateninsIBA 01/2023
1	Neurofibromin 2 (Merlin)IBA 01/2022
1	MART-1 AntigenIBA 01/2022
1	Cytostatic AgentsIBA 01/2022
1	ChemokinesIBA 01/2022
1	Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA 01/2022
1	Phospho-Specific AntibodiesIBA 01/2022
1	MucinsIBA 01/2021
1	Activating Transcription Factor 1IBA 01/2021
1	somatostatin receptor 2IBA 01/2021
1	MyogeninIBA 01/2021
1	ErbB Receptors (EGF Receptor)IBA 01/2021
1	Lysine (L-Lysine)FDA Link 01/2020
1	Codon (Codons)IBA 01/2020
1	Leucine (L-Leucine)FDA Link 01/2020
1	Type 1 Fibroblast Growth Factor Receptor (Fibroblast Growth Factor Receptor 1)IBA 01/2020
1	Isoleucine (L-Isoleucine)FDA Link 01/2020
1	VimentinIBA 01/2020
1	Mucin-1 (CA 15-3 Antigen)IBA 01/2020
1	Progesterone Receptors (Progesterone Receptor)IBA 05/2019
1	Progesterone FDA LinkGeneric 05/2019
1	Estrogens (Estrogen)FDA Link 05/2019
1	GTP Phosphohydrolases (GTPases)IBA 01/2019

Therapy/Procedure

20	Therapeutics 05/2024 - 05/2009
8	Drug Therapy (Chemotherapy) 11/2021 - 03/2005
6	Radiotherapy 12/2023 - 01/2017
1	Conformal Radiotherapy 12/2022
1	Immunotherapy 01/2022
1	Aftercare (After-Treatment) 01/2021
1	Neoadjuvant Therapy 01/2021
1	Combined Modality Therapy 01/2021